Restera

Restera is a clinical-stage medical technology company developing a first-of-its-kind injectable neurostimulation treatment for obstructive sleep apnea. The company's miniature implant is designed to be placed through a needle in a simple outpatient procedure using ultrasound guidance and precision placement tools. During sleep, the device stimulates neural targets including the Hypoglossal nerve to open the airway and restore breathing. Backed by 6 clinical studies, 68 subjects, 54 patents, and 15 peer-reviewed publications, Restera is advancing a transformative alternative to CPAP therapy.